Press-release for stocks related to sales for sny

GSK Sees Sales Uptick in 2023 Fueled by Vaccines for RSV and Shingles
Published: 2024-02-02 (Crawled : 17:00) - biospace.com/
SNY | News | $46.34 2.09% 620K

Health Technology

| -6.09% | O: -0.93% H: 0.0% C: 0.0%
sales rsv

Press Release: Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline
Published: 2024-02-01 (Crawled : 07:00) - globenewswire.com
SNYNF | News | $92.7 600K

Health Technology

| -8.22% | O: -4.37% H: 0.0% C: 0.0%
SNY | News | $46.34 2.09% 620K

Health Technology

| -11.03% | O: -5.26% H: 0.0% C: 0.0%
sales business pipeline immunology sanofi growth

Non-Injectable Insulin Sales to Surge at 9.50% CAGR by 2034, Fueled by R&D and Innovation | Future Market Insights, Inc
Published: 2023-11-23 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 600K

Health Technology

| Email alert Add to watchlist
MNKD | $4.105 0.61% 260K

Health Technology

| Email alert Add to watchlist
SNY | News | $46.34 2.09% 620K

Health Technology

| Email alert Add to watchlist
sales innovation insulin market

Seagen Second Quarter 2023 Financial Results Demonstrate Exceptional Commercial Performance Driving Record Product Sales with Strong Growth and Momentum
Published: 2023-08-02 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 600K

Health Technology

| -12.55% | O: -2.23% H: 0.0% C: -0.56%
SGEN | $228.74 0.1% 20M

Health Technology

| 18.86% | O: 0.08% H: 0.43% C: 0.2%
SNY | News | $46.34 2.09% 620K

Health Technology

| -15.03% | O: -2.64% H: 0.0% C: 0.0%
sales momentum commercial financial results growth

Rémy Cointreau: 2022-23: Strong Growth in Sales – Business Wire
Published: 2023-04-28 (Crawled : 08:00) - spacfeed.com
PGSS | $10.495 3.2% 2.1K

n/a

| -3.14% | O: 0.38% H: 0.0% C: 0.0%
SNYNF | News | $92.7 600K

Health Technology

| -16.75% | O: -1.21% H: 0.12% C: -2.76%
BY 4 | $20.42 1.69% 11K

Finance

| 4.11% | O: 4.74% H: 0.0% C: -3.83%
SNY | News | $46.34 2.09% 620K

Health Technology

| -18.34% | O: -2.09% H: 0.0% C: 0.0%
sales business growth

Press Release : Strong sales performance and double digit EPS growth marking the achievement of the 2022 profitability milestone
Published: 2023-02-03 (Crawled : 07:00) - globenewswire.com
SNYNF | News | $92.7 600K

Health Technology

| -5.94% | O: -5.75% H: 0.0% C: 0.0%
SNY | News | $46.34 2.09% 620K

Health Technology

| -4.89% | O: -4.01% H: 0.0% C: 0.0%
sales growth milestone

Regeneron's Dupixent and Eylea Offset Drop in COVID-19 Antibody Sales
Published: 2022-08-03 (Crawled : 18:00) - biospace.com/
SNYNF | News | $92.7 600K

Health Technology

| -8.03% | O: -2.6% H: 0.0% C: -0.76%
SNY | News | $46.34 2.09% 620K

Health Technology

| -8.18% | O: -0.17% H: 0.12% C: -1.29%
covid-19 sales eylea drop antibody dupixent

7MM COVID-19 Vaccines Market Outlook 2021-2026 incl. an Excel Model w/ Patient-based Sales Forecasts
Published: 2022-01-13 (Crawled : 15:30) - prnewswire.com
SNYNF | News | $92.7 600K

Health Technology

| -11.65% | O: 0.0% H: 0.0% C: 0.0%
JNJ | News | $146.39 0.45% 1.8M

Health Technology

| -14.6% | O: -0.14% H: 0.0% C: 0.0%
SNY | News | $46.34 2.09% 620K

Health Technology

| -11.46% | O: -0.74% H: 0.0% C: 0.0%
covid-19 sales covid cel vaccine

Empower your medtech sales team and generate more deals
Published: 2021-12-14 (Crawled : 00:00) - modeln.com
SNYNF | News | $92.7 600K

Health Technology

| -0.91% | O: 4.76% H: 2.5% C: 2.5%
SNY | News | $46.34 2.09% 620K

Health Technology

| -5.87% | O: -0.05% H: 0.0% C: 0.0%
sales als deal

Generic Injectable Market to Top US$ 85 Bn by 2031, Growing Burden of Lifestyle Diseases to Accelerate the Sales: FMI
Published: 2021-11-24 (Crawled : 12:30) - prnewswire.com
SNYNF | News | $92.7 600K

Health Technology

| -7.3% | O: -1.33% H: 0.0% C: 0.0%
AZNCF | $138.24 800

Health Technology

| 20.54% | O: -0.02% H: 1.33% C: 1.33%
NVSEF | $93.6375 6.88% 82K

Health Technology

| 15.03% | O: -0.76% H: 0.0% C: 0.0%
NVS | $93.815 1.35% 410K

Health Technology

| 13.29% | O: -0.41% H: 0.2% C: 0.11%
LLY | $731.1 -1.99% 1M

Health Technology

| 189.12% | O: 1.19% H: 0.83% C: -0.29%
SNY | News | $46.34 2.09% 620K

Health Technology

| -8.39% | O: -1.55% H: 0.0% C: 0.0%
AZN | $68.545 0.27% 1.2M

Health Technology

| 21.17% | O: -0.07% H: 0.0% C: 0.0%
disease sales growing

Europe Biosimilars Market, Dosage, Price, Sales & Clinical Trials Report 2021-2026: Adalimumab (Humira) is Currently Dominating the $10 Billion Market
Published: 2021-08-27 (Crawled : 18:00) - prnewswire.com
SNY | News | $46.34 2.09% 620K

Health Technology

| -12.21% | O: -0.06% H: 0.0% C: 0.0%
sales europe clinical trials trial biosimilar

Sales growth accelerated - Full-year guidance raised
Published: 2021-07-29 (Crawled : 06:00) - globenewswire.com
SNY | News | $46.34 2.09% 620K

Health Technology

| -12.58% | O: -0.69% H: 0.08% C: -0.33%
sales growth

Pfizer Pauses Global Sales of Smoking-Cessation Drug Chantix Over Possible Carcinogen Contamination
Published: 2021-06-25 (Crawled : 16:00) - biospace.com/
SNY | News | $46.34 2.09% 620K

Health Technology

| -13.02% | O: 0.55% H: 0.68% C: 0.57%
sales drug

Pfizer Pauses Global Sales of Smoking-Cessation Drug Chantix Over Possible Ca...
Published: 2021-06-25 (Crawled : 16:00) - biospace.com/
SNY | News | $46.34 2.09% 620K

Health Technology

| -13.02% | O: 0.55% H: 0.68% C: 0.57%
sales drug

Herborium Sales for First Quarter 2021 rises 20% Debt decreased $500.000
Published: 2021-06-23 (Crawled : 12:15) - globenewswire.com
SNY | News | $46.34 2.09% 620K

Health Technology

| -12.98% | O: 0.59% H: 0.02% C: -1.01%
sales